Cargando…

The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer

Estrogens have important roles in endometrial cancer (EC) and exert biological effects through the classical estrogen receptors (ERs) ERα and ERβ, and the G-protein–coupled ER, GPER. So far, the co-expression of these three types of ERs has not been studied in EC. We investigated ERα, ERβ, GPER mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hojnik, Marko, Sinreih, Maša, Anko, Maja, Hevir-Kene, Neli, Knific, Tamara, Pirš, Boštjan, Grazio, Snježana Frković, Rižner, Tea Lanišnik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918160/ https://www.ncbi.nlm.nih.gov/pubmed/36769338 http://dx.doi.org/10.3390/ijms24033009

Ejemplares similares

The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer
por: Sinreih, Maša, et al.
Publicado: (2017)

Altered Profile of E1-S Transporters in Endometrial Cancer: Lower Protein Levels of ABCG2 and OSTβ and Up-Regulation of SLCO1B3 Expression
por: Pavlič, Renata, et al.
Publicado: (2021)

Data on expression of genes involved in estrogen and progesterone action, inflammation and differentiation according to demographic, histopathological and clinical characteristics of endometrial cancer patients
por: Sinreih, Maša, et al.
Publicado: (2017)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2020)

Physiological Concentrations of Cimicifuga racemosa Extract Do Not Affect Expression of Genes Involved in Estrogen Biosynthesis and Action in Endometrial and Ovarian Cell Lines
por: Sinreih, Maša, et al.
Publicado: (2022)

AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
por: Hojnik, Marko, et al.
Publicado: (2022)

In the Model Cell Lines of Moderately and Poorly Differentiated Endometrial Carcinoma, Estrogens Can Be Formed via the Sulfatase Pathway
por: Pavlič, Renata, et al.
Publicado: (2021)

Models including preoperative plasma levels of angiogenic factors, leptin and IL-8 as potential biomarkers of endometrial cancer
por: Roškar, Luka, et al.
Publicado: (2022)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Tie-2, G-CSF, and Leptin as Promising Diagnostic Biomarkers for Endometrial Cancer: A Pilot Study
por: Roškar, Luka, et al.
Publicado: (2021)

Combined Liquid Chromatography–Tandem Mass Spectrometry Analysis of Progesterone Metabolites
por: Sinreih, Maša, et al.
Publicado: (2015)

Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
por: Sinreih, Maša, et al.
Publicado: (2021)

Estrogens and the Schrödinger’s Cat in the Ovarian Tumor Microenvironment
por: Gjorgoska, Marija, et al.
Publicado: (2021)

Targeting the formation of estrogens for treatment of hormone dependent diseases–current status
por: Rižner, Tea Lanišnik, et al.
Publicado: (2023)

Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis
por: Pavlič, Renata, et al.
Publicado: (2022)

The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers
por: Rižner, Tea Lanišnik, et al.
Publicado: (2017)

Antibody Arrays Identified Cycle-Dependent Plasma Biomarker Candidates of Peritoneal Endometriosis
por: Pušić, Maja, et al.
Publicado: (2022)

Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer
por: Roškar, Luka, et al.
Publicado: (2021)

Deciphering of a Putative GPER Recognition Domain in ERα and ERα36
por: Acramel, Alexandre, et al.
Publicado: (2022)

Editorial: Translational research for better diagnosis and treatment of endometrial cancer
por: Romano, Andrea, et al.
Publicado: (2023)

The Estrogen-Induced Effects on Myometrium Are the Result of Activation of Two Different Receptor Types: GPER and ERα
por: TICA, O.S., et al.
Publicado: (2015)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases
por: Rižner, Tea Lanišnik
Publicado: (2016)

Editorial: Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery
por: Rižner, Tea Lanišnik
Publicado: (2019)

Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls
por: Knific, Tamara, et al.
Publicado: (2019)

NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer
por: Meng, Ran, et al.
Publicado: (2016)

Decreased Gene Expression of Antiangiogenic Factors in Endometrial Cancer: qPCR Analysis and Machine Learning Modelling
por: Roškar, Luka, et al.
Publicado: (2023)

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
por: Krakstad, C, et al.
Publicado: (2012)

Editorial: Women in experimental pharmacology and drug discovery: 2021
por: Rižner, Tea Lanišnik, et al.
Publicado: (2022)

Association between polymorphisms in segregation genes BUB1B and TTK and gastric cancer risk
por: Hudler, Petra, et al.
Publicado: (2016)

The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis
por: Talia, Marianna, et al.
Publicado: (2020)

Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer
por: Cerne, Jasmina-Ziva, et al.
Publicado: (2011)

TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis
por: Janša, Vid, et al.
Publicado: (2023)

Effects of ICI 182,780, an ERα and ERβ antagonist, and G-1, a GPER agonist, on autophagy in breast cancer cells
por: Muler, Mari Luminosa, et al.
Publicado: (2020)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer
por: Kampa, Marilena, et al.
Publicado: (2023)

Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review
por: Tokarz, Janina, et al.
Publicado: (2020)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells
por: Vo, Diep-Khanh Ho, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_esb26rhl6f1mca79jou5u8jjkt